NCT03658018撤回不适用
A Prospective, Open-Label, Single-Arm, Single-Center Study of Intraosseous Basivertebral Nerve Ablation for the Treatment of Chronic Low Back Pain
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 试验地点
- 2
- 主要终点
- Oswestry Disability Index (ODI)
研究概览
简要总结
Objective of study is to evaluate the procedural success rate, clinical effectiveness, and heath-economic profile using the Intercept Intraosseous Nerve Ablation System in adult subjects with chronic low back pain in the post-market setting
详细描述
This is a prospective, open-label, single-arm, single-center study. There is no randomization or blinding. Subjects will receive the Intercept System procedure to treat one or two motion segments at L3/L4, L4/L5, or L5/S1 as identified by Modic Type 1 or 2 changes.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 25 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Skeletally mature subjects age 25-70 years, inclusive
- •Chronic lower back pain for at least six months
- •Failure to respond to at least six months of non-operative conservative management
- •Oswestry Disability Index (ODI) at time of evaluation of at least 30 points
- •Modic changes (Type 1 or 2) in at least one vertebral endplate, at one or more levels from L3 to S1
排除标准
- •Radicular pain by history or evidence of pain neurological deficit within the past one year.
- •Previous surgery performed on the lumbar spine
- •Current or history of symptomatic spinal stenosis
- •Current or history of osteoporotic or tumor-related vertebral body compression fracture
- •Current or history of vertebral cancer or spinal metastasis
- •Current or history of spinal infection
- •Metabolic bone disease
- •BMI greater or equal to 40
- •Any radiographic evidence of other important back pathology
- •MRI evidence of Modic changes, Type 1 or 2 at greater than 3 vertebral bodies or at non-consecutive levels, or at vertebral bodies other than L3 to S1
- •Any back pathology related to trauma, evidence of vertebral compression fracture or other spinal pathology that could affect assessment of response to back pain
- •Subjects who are bed bound
- •Demonstrates 3 or more Waddell's signs of Inorganic Behavior
- •Any evidence of current systemic infection
研究组 & 干预措施
Intracept System Ablation
Experimental
干预措施: Intracept System Ablation (Device)
结局指标
主要结局
Oswestry Disability Index (ODI)
时间窗: 3 months
Mean change in Oswestry Disability Index Score from baseline to 3 months post-treatment. Scale is measured from 0 to 100, better to worse respectively.
次要结局
- Visual Analog Scale (VAS)(3, 6, 9, and 12 months)
- Oswestry Disability Index (ODI)(6, 9, and 12 months)
研究者
研究点 (2)
Loading locations...
相似试验
撤回
不适用
Intraosseous Basivertebral Nerve Ablation for the Treatment of Chronic Low Back PainChronic Low Back PainNCT03630133Relievant Medsystems, Inc.
已完成
不适用
Ultra-high Frequency (500 KHz) Spinal Cord Stimulation for Treatment of Chronic Back Pain or Lower Limb PainPain, ChronicPain, BackPain, RadiatingNCT03543085GiMer Medical10
已完成
不适用
The Vertos MILD™ Preliminary Patient Evaluation StudyLumbar Spinal StenosisNCT00749073Vertos Medical, Inc.10
已完成
早期 1 期
A Clinical Study Evaluating the Safety and Efficacy of CS-101 in Treating Subjects With β-thalassemiaBeta-ThalassemiaNCT06024876CorrectSequence Therapeutics Co., Ltd5
Enrolling By Invitation
1 期
CS-101 in Patients With β-thalassemiaBeta-ThalassemiaNCT06328764CorrectSequence Therapeutics Co., Ltd10